Ask AI

Downloadable Living Slides

Share

Program Content

Activities

  • CAR T Cell and Bispecific Antibodies in Multiple Myeloma
    Combating Myeloma: Improving Access and Outcomes With CAR T-Cell and Bispecific Antibody Therapies in Veterans With Relapsed/Refractory Multiple Myeloma
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 25, 2025

Provided by

ProCE Banner

Clinical Care Options, LLC.

Supporters

Supported by educational grants from Bristol Myers Squibb and Johnson & Johnson.

Bristol Myers Squibb

Johnson & Johnson